Nuedexta

Johnny Pillpusher is tired of the Bullshit. He drives his Ford Edge to the Vatican and knocks at the Pope's door. The Pope opens the door and Johnny says: "I am tired of living a frustrating live selling overpriced cough syrup. I want to give my live to the Lord". The Pope says, "Perfect son, you came to the right place, let me show you around". So the Pope shows him the Vatican. Afterwards, Jonny says, "Well, that's all nice and dandy, but where can I fuck?" The Pope says, " No worry, son, the Lord has taken care of everything" and the two go into a very old building. An endless stairwell leads them down to a dimly lit room. In the center of the room is a coffin on a table. In the center is a small round hole. The Pope, pointing to the coffin, says, "Here you can enjoy yourself Monday, Tuesday, Wednesday, Thursday, Friday and Sunday." Johnny says: "Well, that's all nice and dandy, but what about Saturdays?" The Pope laughs and says: "Haha, on Saturday your ass is in that box!"

 

This identifies the problem with the salesforce for Neudexta: They are obviously staffed with 12 year olds. What is your problem, friend?

 

Managers are pushing off label ???

 

Au contraire, my friend! Selling dextromethorphane and quinidine, two very cheap and old generic drugs for over $1000!! a month is hardly ethical!

 

Hey how is that "positive tension" thing going on those 15 second calls?

Management is so full of themselves!!

 

Pricing this concoction for over $1200 a month gives our industry a horrible image and reputation, and justifiably so!! I don't know how anyone can look at himself/herself in the mirror at the end of the day and say "I am proud of what I am doing!"

Patients with TBIs face significant challenges at work (providing they are working) and in social situations. They may not even have any health insurance. And you are doing a great job contributing to their financial
problems! For $1200 a month a family of four can get an entire month of health insurance! And we are charging this for one month of dextromethorphan and quinidine? We are contributing to the patients problems!! Pure G-R-E-E-D!!!

 

Just as ethical as the 2 girls in SC selling off label with their manager knowing it.

 

Why are you concerning yourself with the patient? That is not your job!! Your job is to sell!! That's what you were hired for! Worry about your metrics and do your job!! If you don't like it here, become a plumber. $40 per hour and all you can eat!! We can find plenty of people that will gladly drink the company kool-aid and stick them in a car!!

Instead of complaining about laughable $1200 a month you should bring some VALUE to your offices. You can do this by bringing a big smile, pizza, and great resources, like the visaid, to the office! If a provider has only two minutes you need to tell him: "Doc, we are not done talking!! I have important, company approved messages, that you need to listen to, and I expect you to listen up, you get that? I am not here for the fun of it!" After all you are bringing pizza and pepsi!! Look the provider straight in the eye and put your foot down. That's what successful reps do!! There is NO excuse not to listen too you!! Remember, you are part of there treatment team!!

Positive tension!! How else are you going to make your quotas and be successful?

When I come into town to work with the DSMs and reps I stay in the most expensive hotel money can buy. A Hyatt or Hilton just won't cut it. I am sure you understand that a person like myself is absolutely entitled to that. Being frugal does not apply to me! Therefore we can't charge a lower price for Nuedexta. Somewhere the money must come from!! It's only common sense!!

 

"Cash rolls into Congress to defend a battled industry"

From Fierce Pharma:


In the heat of the most ferocious battle over drug prices in years, pharmaceutical companies are showering U.S. senators with campaign cash as sweeping legislation heads toward the floor.


In the first six months of this year alone, political action committees run by employees of drug companies and their trade groups have given the 30 senators expected to run for reelection nearly $845,000, the latest update to Kaiser Health News’ “Pharma Cash to Congress” database shows. That hefty sum stands out with Election Day more than 14 months away.

Lowering drug prices is one of the rare causes that has united Democrats and Republicans, and at least one proposal that would change the way the industry does business could get a vote in Congress this year. One of the most promising and aggressive updates would cap drug prices under Medicare so they do not outpace inflation.

The number of big contributions and the lawmakers receiving them signal the industry is building loyalty as voters push candidates to talk about drug prices in the 2020 elections.

For the drug industry, the stakes are high.

“If the Senate flips” to Democrats, “then PhRMA’s probably going to have to double its budget,” said Kent Cooper, a former Federal Election Commission official who has tracked political money for decades, referring to the industry’s biggest lobbying group, the Pharmaceutical Research and Manufacturers of America.

Most of the biggest donations in the first half of 2019 have gone to Republicans, who control the Senate and tend to be more reluctant to restrict drugmakers. And even those who do not serve on committees that oversee the industry or represent states with significant industry ties have benefited from drugmaker cash this year.

“We support candidates from both political parties who support innovation and patient access to medicines,” said PhRMA spokeswoman Holly Campbell.

Several senators facing tough reelection campaigns have raked in tens of thousands of dollars this year, with some collecting much more than the industry has given them in the past decade, if ever.

“If it looks as though somebody is going to have a tough run — maybe a friend, maybe somebody you want to develop a better relationship with — you put some extra money in place,” said Steven Billet, a former AT&T lobbyist who teaches PAC management at George Washington University.

Thus far, senators running for reelection have together pulled in over $115,000 more than the 27 senators who were running for reelection in mid-2017.

The biggest single beneficiaries were Sens. Chris Coons, a Democrat from Delaware, and Thom Tillis, a North Carolina Republican, who took in a whopping $103,000 and $102,000 respectively in the first six months of the year. Tillis and Coons, the leaders of a Senate subcommittee on intellectual property, have been working on legislation to overhaul the patent system — perhaps the most powerful tool brand-name drugmakers have to keep prices, and profits, high.

Sen. John Cornyn (R-Texas) has been a vocal critic of the way some drugmakers use patents to extend their monopolies on drugs and block competitors, introducing a bill that would empower the government to sue drugmakers for gaming the system.

Cornyn, who faces a difficult reelection fight, received about $65,500.

Another top recipient was Sen. Cory Gardner of Colorado, who is considered the most vulnerable Republican up for reelection in 2020. John Hickenlooper, the state’s former governor who dropped out of the Democratic presidential primary on Aug. 15, has decided to challenge Gardner, further complicating his chances of being reelected.

Despite Gardner’s lack of pharma-related committee assignments, he received about $81,000 from drugmaker PACs this year, ranking him among the top 10 recipients of pharma cash in Congress. Another vulnerable Republican incumbent, Sen. Joni Ernst of Iowa, received about $35,500 — a huge bump for a lawmaker who, before this year, had collected about $15,000 total during her first term.

Sen. Gary Peters (D-Mich.) is also considered in danger as he runs for reelection in a state that voted for President Donald Trump in 2016. Like Gardner and Ernst, he does not serve on key committees, nor has he played a high-profile role in this year’s pushes on drug prices.

Peters received about $49,500 in campaign contributions from drugmaker PACs in the first half of the year, a personal record since being sworn in in 2015. Last year he received about $10,500 from drugmaker PACs in total.

Congressional leaders, who also help fund the campaigns of party members, are a common target of pharmaceutical industry contributions. And with Republicans controlling what legislation comes up in the Senate, Majority Leader Mitch McConnell, also running for reelection, has seen an uptick in donations: He received more than $85,000 during the first half of the year, a record for him over the course of the past eight years.

Drugmaker PACs typically give to most members of Congress, regardless of party. But with Democrats pushing some of the most aggressive proposals to regulate drugmakers, the industry may stand to lose more ground should Democrats regain control of Congress — and political experts say that is a possibility. Democrats are likely to make drug prices a key campaign issue.

“While it may not be true at this very moment, it may well be true that the Democrats will have enough seats in play to really fight for the majority,” said Jennifer Duffy, a senior editor at the nonpartisan Cook Political Report. “I think it’s a tossup at this point.”

The 19 Senate Republicans running in 2020 collected an average of more than $32,500 each from the pharmaceutical industry, while the 11 Democrats collected an average of nearly $20,500 each.

Sen. Bill Cassidy, a Louisiana Republican who is a gastroenterologist by trade and has been active on health care issues, received about $76,000 from drugmaker PACs in the first half of the year despite the likelihood he will be reelected next year.

Pharmaceutical company PAC contributions are only part of the picture, though. Dollars from individual drug company employees may flow in the same direction, as well as “dark money” spending that often dwarfs what must be disclosed.

“The PAC contribution is a signal to other folks who are associated with the industry,” Billet said.

PhRMA gives hard-to-trace millions to American Action Network and other conservative groups that buy TV ads and robocalls and engage in other political advocacy.

Drug prices have been among Americans’ top concerns for years. Large, bipartisan majorities favor policies to control drug costs, including importing drugs from Canada and government negotiations to lower prices paid by Medicare.

Prescription prices remain far higher in the U.S. than in other wealthy countries. Prices for hospital medicines continue to rise. High-deductible health plans have increased the number of patients who feel the drug-price sting directly before insurance kicks in.

New therapies such as genetically altered immune cells to fight cancer, which can cost $1 million per treatment, threaten to renew the cost spiral.

The House also saw an uptick in donations from drug industry PACs during the first half of the year, with the Republican leader, Rep. Kevin McCarthy of California, and the top Republican on the House Energy and Commerce Committee, Rep. Greg Walden of Oregon, taking in the most. McCarthy received about $89,000, while Walden collected about $86,500.

Speaker Nancy Pelosi of California, the powerful Democrat who controls the House and is working on a plan to empower federal health officials to negotiate drug prices, took in about $12,500.

Kaiser Health News is a nonprofit news service covering health issues. It is an editorially independent program of the Kaiser Family Foundation, which is not affiliated with Kaiser Permanente.

NOTE BY OP: PACs benefit very FEW at the expense of MANY!! Anyone who accepts a donation from a PAC is much less likely to make a decision in favor of his/her constituents! So it is unlikely that the recipients will act in favor of the American consumer, instead allow drug companies to charge outrageous prices for their products!! Keep this in mind, YOU are also a consumer!!

 

You must be either a manager or director with a comment like this.
Now let me ask you: Do you have any hairs in your nose?
I have some in my ass, perhaps we can tie them together!

 

I am sure Otsuka is sooo happy for having jumped in bed with Avanir and mated.
The baby named Nuedexta is such a contribution to humanity.

In my territory, Docs stop seeing their patients immediately just to talk to me. After the vis aid commercial they pay me $100, kiss my feet and open the door to my car, so that I, the entitled king, can drive off to see the next doctor who is standing outside his office waving me in the door.

 

I saw a new psychiatrist in my territory last week for the first time. He was young, just out of medical school.
Tried talking about Nuedexta...

Doc with an elevated voice: "THIS IS ABSOLUTE JUNK WITH NO OTHER PURPOSE TO PUT MONEY INTO THE COFFERS OF PHARMACEUTICAL COMPANIES. AND YOU PROSTITUTE YOURSELF SELLING THIS GARBAGE!!

Me: "Totally agree with you on both points, sir."

Doc: ???...."WHAT ARE YOU CHARGING FOR THIS?"

Me:" Cashprice at Walmart is only $1200 and some change per month..."

Doc: "GET OUTTA HERE AND NEVER COME BACK!!"

Aahh, that felt soooo good...Everyone likes warm fuzzies!!

 

Haha, love it...Only a good rim job feels better!!! Bend over now!!